Beijing Biostar Pharmaceuticals Co., Ltd. is a national high-tech enterprise focusing on the development of oncology products with independent intellectual property through state-of-the-art technology platforms such as combinatorial biosynthesis. Beijing Biostar has become an integrated biopharmaceutical company encompassing R&D, manufacturing, and commercialization capabilities. Utidelone injection, an innovative product inde...
Beijing Biostar Pharmaceuticals Co., Ltd. is a national high-tech enterprise focusing on the development of oncology products with independent intellectual property through state-of-the-art technology platforms such as combinatorial biosynthesis. Beijing Biostar has become an integrated biopharmaceutical company encompassing R&D, manufacturing, and commercialization capabilities. Utidelone injection, an innovative product independently developed by Beijing Biostar, is the new-generation microtubule inhibitor produced by the microbial fermentation process and has been approved by the NMPA in March 2021.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.